1203 STING/type i interferon pathway activation in patients with perniosis during the COVID–19 pandemic
Ying Zheng,
Xizhang Sun,
Lena Tanaka,
Keith B Elkon,
Jie An,
Andrea Kalus,
Sarah Chung,
Brandon Seaton,
Ata Moshiri,
Daniel Lih,
Hari Krishnamurthy
Affiliations
Ying Zheng
4 Stroke and Applied Neuroscience Center, University of Washington, Seattle, WA, USA
Xizhang Sun
1Division of Rheumatology, University of Washington, Seattle, Washington, USA
Lena Tanaka
1Division of Rheumatology, University of Washington, Seattle, Washington, USA
Keith B Elkon
1Division of Rheumatology, University of Washington, Seattle, Washington, USA
Jie An
University of Washington, Department of Medicine and Immunology, Biochemistry, Bioengineering, Medicinal Chemistry, University of Washington, Seattle, WA, USA
Andrea Kalus
2Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA
Sarah Chung
1Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA
Brandon Seaton
3Clinical Trials Pathology Lab, Fred Hutchinson Cancer Research Center, Seattle, WA
Ata Moshiri
2Division of Dermatology, Department of Medicine, University of Washington, Seattle, WA
Daniel Lih
4Department of Bioengineering, University of Washington, Seattle, WA
Hari Krishnamurthy
5Vibrant America Clinical Lab, Vibrant America, San Carlos, CA 94070
